Credit Suisse’s Akcea Therapeutics, Inc. Common Stock AKCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-392,768
| Closed | -$7.13M | – | 3647 |
|
|
2020
Q3 | $7.13M | Buy |
392,768
+377,115
| +2,409% | +$6.84M | ﹤0.01% | 1130 |
|
|
2020
Q2 | $214K | Sell |
15,653
-674
| -4% | -$9.22K | ﹤0.01% | 3068 |
|
|
2020
Q1 | $234K | Sell |
16,327
-7,095
| -30% | -$102K | ﹤0.01% | 2962 |
|
|
2019
Q4 | $397K | Buy |
23,422
+11,337
| +94% | +$192K | ﹤0.01% | 3032 |
|
|
2019
Q3 | $186K | Sell |
12,085
-2,545
| -17% | -$39.2K | ﹤0.01% | 3208 |
|
|
2019
Q2 | $343K | Sell |
14,630
-12,345
| -46% | -$289K | ﹤0.01% | 2978 |
|
|
2019
Q1 | $764K | Buy |
26,975
+12,904
| +92% | +$365K | ﹤0.01% | 2546 |
|
|
2018
Q4 | $425K | Buy |
14,071
+2,230
| +19% | +$67.4K | ﹤0.01% | 2823 |
|
|
2018
Q3 | $415K | Sell |
11,841
-2,382
| -17% | -$83.5K | ﹤0.01% | 2928 |
|
|
2018
Q2 | $337K | Sell |
14,223
-12,142
| -46% | -$288K | ﹤0.01% | 3131 |
|
|
2018
Q1 | $676K | Sell |
26,365
-1,369
| -5% | -$35.1K | ﹤0.01% | 2797 |
|
|
2017
Q4 | $482K | Buy |
27,734
+17,701
| +176% | +$308K | ﹤0.01% | 2967 |
|
|
2017
Q3 | $277K | Buy |
+10,033
| New | +$277K | ﹤0.01% | 3298 |
|